Potential of Systemic Allogeneic Mesenchymal Stromal Cell Therapy for Children with Recessive Dystrophic Epidermolysis Bullosa

Affiliations

• ¹ St John's Institute of Dermatology, King's College London (Guy's Campus), London, UK. Electronic address: john.mcgrath@kcl.ac.uk.
• ² St John's Institute of Dermatology, King's College London (Guy's Campus), London, UK.
• ³ St John's Institute of Dermatology, King's College London (Guy's Campus), London, UK; Department of Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.
• ⁴ Cell Therapy Facility, Department of Clinical Pharmacology, University Medical Centre Utrecht, Utrecht, The Netherlands.
• ⁵ Department of Pediatrics, Blood and Marrow Transplantation Program, Wilhelmina Children's Hospital, University Medical Centre Utrecht, Utrecht, The Netherlands.
• ⁶ Department of Pediatrics, Blood and Marrow Transplant, Medical School, University of Minnesota, Minneapolis, Minnesota, USA; Stem Cell Institute, University of Minnesota, Minneapolis, Minnesota, USA.
• ⁷ Blood and Marrow Transplantation Department, Great Ormond Street Hospital, London, UK.
• ⁸ Division of Health and Social Care Research, King's College London, London, UK.
• ⁹ Department of Dermatology, Great Ormond Street Hospital for Children NHS Foundation Trust, London, UK.